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Transcription factorNeuronal activity is highly dependent on energymetabolism.Nuclear respiratory factor 2 (NRF-2) tightly couples
neuronal activity and energy metabolism by transcriptionally co-regulating all 13 subunits of an important
energy-generating enzyme, cytochrome c oxidase (COX), as well as critical subunits of excitatory NMDA recep-
tors. AMPA receptors are another major class of excitatory glutamatergic receptors that mediate most of the fast
excitatory synaptic transmission in the brain. They are heterotetrameric proteins composed of various combina-
tions of GluA1–4 subunits, with GluA2 being the most common one. We have previously shown that GluA2
(Gria2) is transcriptionally regulated by nuclear respiratory factor 1 (NRF-1) and speciﬁcity protein 4 (Sp4),
which also regulate all subunits of COX. However, it was not known if NRF-2 also couples neuronal activity and
energy metabolism by regulating subunits of the AMPA receptors. By means of multiple approaches, including
electrophoretic mobility shift and supershift assays, chromatin immunoprecipitation, promoter mutations,
real-time quantitative PCR, and western blot analysis, NRF-2 was found to functionally regulate the expression
ofGria2, but not ofGria1, Gria3, orGria4 genes in neurons. By regulating the GluA2 subunit of the AMPA receptor,
NRF-2 couples energy metabolism and neuronal activity at the transcriptional level through a concurrent and
parallel mechanism with NRF-1 and Sp4.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
The alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
(AMPA) receptors are a major class of excitatory glutamatergic recep-
tors that mediate the majority of fast excitatory synaptic transmission
in the mammalian central nervous system (for review see [1]). AMPA
receptors are widely expressed and are important for normal neuronal
activity, including excitatory neurotransmission, synaptic plasticity,
synaptic scaling, homeostatic synaptic plasticity, and learning and
memory (for reviews see [2–4]). AMPA receptors are heterotetrameric
proteins composed of various combinations of the GluA1, GluA2,
GluA3, and GluA4 subunits (for review see [5]). The predominant
AMPA receptor subtypes in the cerebral neocortex, hippocampus, and
in pyramidal cells of the brain are heterotetramers containing the
GluA1 and GluA2 subunits [6,7]. The expression of the GluA3 and
GluA4 subunits is much lower than that of GluA1 or GluA2, with
GluA4 present mainly during development [6,8,9].
Glutamatergic neurotransmission is a highly energy-demanding
process, with most of this energy utilized to pump out excess cations
that enter the cell after glutamatergic receptor activation [10,11]., gene name for AMPA receptor
1 414 955 6517.Thus, there is an intimate link between neuronal activity and energy
metabolism at the cellular level. Recently, we found that the coupling
between neuronal activity and energy metabolism extends to the mo-
lecular level. The same transcription factors, nuclear respiratory factor
1 (NRF-1) and speciﬁcity protein 4 (Sp4), co-regulate energy metabo-
lism and neuronal activity by regulating the expression of all 13 sub-
units of the energy-generating enzyme, cytochrome c oxidase (COX),
as well as the expression of critical subunits of the excitatory AMPA
and N-methyl-D-aspartate (NMDA) glutamatergic receptors [12–17].
Besides NRF-1, nuclear respiratory factor 2 (NRF-2) is also a tran-
scription factor that co-regulates the expression of all 13 subunits of
COX and critical subunits of the NMDA receptor [18–20]. It is not
known, however, if NRF-2 also regulates the expression of AMPA recep-
tor subunits. If so, three mechanisms are possible by which NRF-2
regulates the AMPA receptor subunits with respect to NRF-1 and Sp4:
complementary, concurrent and parallel, or a combination of comple-
mentary and concurrent/parallel mechanisms. In the complementary
mechanism, NRF-2 regulates AMPA receptor subunits complementary
to those regulated by NRF-1 and Sp4. In the concurrent and parallel
mechanism, NRF-2, NRF-1, and Sp4 jointly regulate the same AMPA
receptor subunit genes in a parallel fashion (all are stimulatory). In a
combination of the complementary and concurrent/parallel mecha-
nisms, a subset of subunit genes is controlled by all three transcription
factors, whereas another subset is controlled by NRF-2 separately from
NRF-1 and Sp4.
Table 1A
EMSAprobes. Positions of probes are given relative to TSP. PutativeNRF-2 binding sites are
underlined.
Gene
promoter
Position EMSA sequence
Gria1 +198/+221 F: 5′ TTTTAGAAGGAAGGGAGGAAGGAAAGAA 3′
R: 5′ TTTTTTCTTTCCTTCCTCCCTTCCTTCT 3′
Gria2 −327/−298 F: 5′ TTTTCGGCTTCCTAGGCATAGCAACCGGAAATCA 3′
R: 5′ TTTTTGATTTCCGGTTGCTATGCCTAGGAAGCCG 3′
Gria3 +101/+117 F: 5′ TTTTGGGTGGAAAGGAAGAGT 3′
R: 5′ TTTTACTCTTCCTTTCCACCC 3′
Gria4 +403/+420 F: 5′ TTTTTGGGGGAAAGGGAATGGG 3′
R: 5′ TTTTCCCATTCCCTTTCCCCCA 3′
COX6b −47/−23 F: 5′ TTTTTCCTCTTGCAGCTTCCGGCCAGTC 3′
R: 5′ TTTTGACTGGCCGGAAGCTGCAAGAGGA 3′
Table 1B
Mutant EMSAprobes. Positions of probes are given relative to TSP. MutatedNRF-2 binding
sites are underlined.
Gene
promoter
Position Sequence
Gria1 +198/+221 F: 5′ TTTTAGAATTTTGGGAGGTTTTAAAGAA 3′
R: 5′ TTTTTTCTTTAAAACCTCCCAAAATTCT 3′
Gria2 −327/−298 F: 5′ TTTTCGGCAAAATAGGCATAGCAACCTTTTATCA 3′
R: 5′ TTTTTGATAAAAGGTTGCTATGCCTATTTTGCCG 3′
3019A. Priya et al. / Biochimica et Biophysica Acta 1843 (2014) 3018–3028The goal of this studywas to test our hypothesis that NRF-2 regulates
the same subunit genes of the AMPA receptors as NRF-1 and Sp4, and
that these two transcription factors function via a concurrent and
parallel mechanism.
2. Material and methods
All experimentswere carried out in accordancewith the US National
Institutes of Health Guide for the care and use of laboratory animals and
the Medical College of Wisconsin regulations. All efforts were made to
minimize the number of animals and their suffering.
2.1. Cell culture
Murine neuroblastoma (N2a) cells (ATCC® CCL-131™, Manassas,
VA, USA) were grown in Dulbecco's modiﬁed Eagle's medium supple-
mented with 10% fetal bovine serum, 50 units/ml penicillin, and
100 μg/ml streptomycin (Invitrogen, Carlsbad, CA, USA) at 37 °C in a
humidiﬁed atmosphere with 5% CO2.
Cultures of rat primary visual cortical neurons were performed ac-
cording to our published protocol [19]. Brieﬂy, 1 to 2-day old rat pups
were euthanized by decapitation. Visual cortical tissue was removed,
trypsinized, and triturated. Individual neurons were plated in poly-
L-lysine-coated, 35 mm dishes at a density of 2 × 105 cells/dish and
maintained in Neurobasal-A media supplemented with B27. Ara-C
(cytosine arabinoside; Sigma, St Louis, MO, USA) was added the
day after plating to suppress the proliferation of glial cells.
2.2. In silico analysis of promoters of murine AMPA receptor subunit genes
DNA sequences surrounding the transcription start point (TSP) of
AMPA receptor subunit genes (Gria1–4) were derived from the NCBI
mouse genome database (Gria1 GenBank ID: NC_000077.6, Gria2
GenBank ID: NC_000069.6, Gria3 GenBank ID: NC_000086.7, and Gria4
GenBank ID: NC_000075.6). Putative promoter sequences encompassing
1 kb upstream and 1 kb downstream of the TSP of each gene were
analyzed. Computer-assisted search for NRF-2's binding motif ‘GGAA’,
or its complement ‘TTCC’, separated by up to 24 base pairs (bp) from an-
other such NRF-2 bindingmotif, was conducted on each promoter, using
DNAStar Lasergene 8 Suite – Sequence Builder and Genequest software.
Alignment of human, mouse, and rat promoter sequences was per-
formedwith NCBI's Ensembl interface. Mouse AMPA receptor promoter
sequences were compared with those of rat and human genomic se-
quences for conservation of the NRF-2 binding motif.
2.3. Electrophoretic mobility shift and supershift assays
Electrophoretic mobility shift assays (EMSA) for possible NRF-2 in-
teractionswith putative binding elements on all AMPA receptor subunit
promoters were carried out with a few modiﬁcations from methods
previously described [19]. Brieﬂy, based on in silico analysis, oligonucle-
otide probes with a putative NRF-2 bindingmotif in a tandem repeat on
each AMPA receptor subunit promoter were synthesized (Table 1A),
annealed, and labeled by a Klenow fragment (Invitrogen, Grand Island,
NY, USA) ﬁll-in reaction with [α-32P] dATP (50 μCi/200 ng; Perkin-
Elmer, Shelton, CT, USA). N2a nuclear extract was isolated using
methods described previously [21]. Each labeled EMSA probe was incu-
batedwith 2 μg of calf thymusDNAand 15 μg of N2a nuclear extract. The
probe reaction was processed for EMSA. Supershift assays were
performedwith 0.4 μg of NRF-2 speciﬁc antibody (polyclonal rabbit an-
tibody, H-180, sc-22810, Santa Cruz Biotechnology, Santa Cruz, CA, USA)
added to the probe/nuclear extract mixture and incubated for 20min at
24 °C. For competition, 100-fold excess of unlabeled oligonucleotides
was incubated with nuclear extract before the addition of labeled oligo-
nucleotides. Shift reactions were loaded onto 4.5% polyacrylamide gel
(58:1, Acrylamide:Bisacrylamide) and run at 200 V for 4.2 h in 0.25XTris–borate–EDTA buffer. Results were visualized by autoradiography
and exposed on ﬁlm. Rat cytochrome c oxidase subunit 6b (COX6b)
with known NRF-2 binding site was designed as previously described
[19] and used as a positive control. NRF-2 mutants with mutated se-
quences, as shown in Table 1B, were used as negative controls.
2.4. Chromatin immunoprecipitation (ChIP) assays in N2a cells
ChIP assays were performed similar to those described previously
[15]. Brieﬂy, 1 × 106 N2a cells were used for each immunoprecipitation
reaction. The cells were ﬁxedwith 1% formaldehyde for 10min at 24 °C.
Following formaldehyde ﬁxation, the cells were resuspended in swell-
ing buffer (5 mM PIPES, pH 8.0, 85 mM KCl, and 1% Nonidet P-40
(Sigma), with protease inhibitors added right before use) and homoge-
nized. Nuclei were then isolated and subjected to sonication in SDS lysis
buffer (1% SDS, 10 mM EDTA, 50 mM Tris–HCl, pH 8.1 (Sigma)). The
sonicated lysate was immunoprecipitated with either 1 μg of NRF-2
polyclonal rabbit antibody (H-180, Santa Cruz Biotechnology) or 2 μg
of anti-nerve growth factor receptor (NGFR) p75 polyclonal goat anti-
body (C20, sc-6188, Santa Cruz Biotechnology). Semi-quantitative PCR
was performed using 1/20th of precipitated chromatin. Primers
encompassing putative NRF-2 tandem repeats near TSPs of AMPA re-
ceptor subunit genes (identiﬁed in silico analysis) were designed
(Table 2). COX6b promoter with NRF-2 binding site was used as a posi-
tive control [19], and exon 8 of NRF-1, a region of DNA that does not
contain a NRF-2 binding site, was used as a negative control (Table 2).
PCR reactions were carried out with DreamTaq polymerase (Thermo-
Fisher Scientiﬁc, Waltham, MA, USA) and products were visualized on
2% agarose gels stained with ethidium bromide.
2.5. ChIP assays from murine visual cortical tissue
ChIP assays were performed on primary neurons similar to that de-
scribed for N2a cells above and as described previously [20]. Brieﬂy,
0.1 g of murine visual cortical tissue was used for each immunoprecip-
itation reaction. Fresh murine visual cortex was quickly dissected and
cut into small pieces. The ﬁnely chopped visual cortical tissue was
ﬁxed with 2% formaldehyde for 20 min at 24 °C. Following formalde-
hyde ﬁxation, the cellswere resuspended in swelling buffer andhomog-
enized as described above. Nuclei isolation and immunoprecipitation, as
well as the analysis of immunoprecipitated samples, including primers
Table 2
Primers and conditions used for ChIP analysis.
Gene promoter Position of PCR product Sequence
Gria1 +166/+323 F: 5′ TCCCCTTCCAAGAGAAACAA 3′
R: 5′ AAAAGAAGCCCTGGTCCAAC 3′
Gria2 −451/−234 F: 5′ AGGCAGAAGGCAGTGTGTG 3′
R: 5′ GCTGAGGTTGCAGGGTTTAC 3′
Gria3 −29/+169 F: 5′ GGGGTGTGAGAGAGATCCTG 3′
R: 5′ AAGAATTCGCCGGCTCTTAC 3′
Gria4 +264/+513 F: 5′ CTCCAGAGCCGGTTCCTC 3′
R: 5′ GGGCTACAGCATCCCTGAG 3′
COX6b −187/+44 F: 5′ AAAGTGCGCAGGCGCTGGAG 3′
R: 5′ CCGAGACGCTGACAGCACCG 3′
Exon 8 of NRF-1 F: 5′ GTGGAACAAAATTGGGCCAC 3′
R: 5′ CTGTTAAGGGCCATGGTGA 3′
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described for N2a cells above.
2.6. Construction and transfection of luciferase reporter vectors for promoter
mutagenesis study
The Gria2 promoter luciferase reporter construct was made by PCR
cloning the Gria2 promoter using genomic DNA prepared from mouse
N2a cells as a template. Digestion with restriction enzymes MluI and
BglII was followed by ligation of the product directionally into pGL3
basic luciferase vector (E1751, Promega, Madison, WI, USA). Sequences
of primers used for PCR cloning are provided in Table 3A. COX6b clone
was used from our previous study as a positive control [19]. Site-
directed mutation of the putative NRF-2 tandem repeat binding site
on Gria2 was generated using QuikChange site-directed mutagenesis
kit (Stratagene, La Jolla, CA, USA). Primers for mutagenesis are listed in
Table 3B. All constructs were veriﬁed by sequencing.
Each promoter construct was transfected into N2a cells in a 24-well
plate using Lipofectamine 2000 (Invitrogen) and cell lysates harvested
after 48 h. Each well received 0.6 μg of reporter construct and 0.06 μg
of pRL-TK renilla luciferase vector (E2241, Promega), a vector with
thymidine kinase (TK) promoter that constitutively expressed renilla
luciferase. Transfected neurons were stimulated with KCl at a ﬁnal
concentration of 20 mM in the culture media for 5 h as previously de-
scribed [22]. After 5 h of treatment, cell lysateswere harvested andmea-
sured for luciferase activity as described previously [22]. Data from six
independent transfections were averaged for each promoter construct.
2.7. Plasmid construction of NRF-2 shRNA, transfection, and KCl treatment
NRF-2 silencing was carried out using two small hairpin RNA
(shRNA) sequences against murine (with identical sequences for rat)able 3A
rimers used for promoter cloning analysis.
Gene
promoter
Position Primer
Gria2 −947/+152 F: 5′ CAGACGCGTCCCAAGCAGGCTCGGTGTAATGA 3′
R: 5′ CAGAGATCTGCTGTGGTCCCGGTGTCTGG 3′
COX6b −291/+44 F: 5′ TTGGTACCACTCTGCAGACAGCCTCAC
R: 5′ TTAAGCTTCGGAGCAGCGTTACTTCAAT
able 3B
rimers used for promoter mutagenesis analysis. Mutated NRF-2 binding sites are underlined.
Gene promoter Position Primer
Mut. NRF-2 Gria2 −333/−288 F: 5′ GCAGTTCGGCTGCTTAGGCATAGCAACCGTACATCAGTTTTGCAGC 3′
R: 5′ GCTGCAAAACTGATGTACGGTTGCTATGCCTAAGCAGCCGAACTGC 3′
Mut NRF-2 COX6b −35/−32 F: 5′ TCTCCTCTTGCAGCTAGAGGCCAGTCGGAATTCCG 3′
R: 5′ CGGAATTCCGACTGGCCTCTAGCTGCAAGAGGAGA 3′T
P
T
PNRF-2α as described previously [18]. Brieﬂy, the pBS/U6 empty parent
vector was used as the negative control. The pLKO.1-puro-CMV-
TurboGFP Positive Control Vector (SHC003, Sigma) containing turboGFP
and puromycin resistance was used to visualize transfection efﬁciency
and select for positively transfected cells.
For transfection of N2a cells, they were plated at 60% conﬂuency in
6-well dishes. The cells were co-transfected the day after plating with
either the NRF-2 shRNA construct (2 μg) and turboGFP (0.5 μg)
vectors or the pBS/U6 empty vector (2 μg) and the turboGFP (0.5 μg)
vector using 5 μl of JetPrime transfection reagent (PolyPlus Transfection,
Illkirch, France) per well. Puromycin at a ﬁnal concentration of 5 μg/ml
was added to the culturemedium1.5 days after transfection to select for
purely transfected cells. Green ﬂuorescence was observed to monitor
transfection efﬁciency. Transfection efﬁciency for N2a cells was around
75%; however, puromycin selection effectively yielded 100% transfected
cells. N2a cells transfectedwith shRNAagainst NRF-2were further stim-
ulated with KCl at a ﬁnal concentration of 20 mM in the culture media
for 5 h as previously described [22]. After 5 h of treatment, the cells
were harvested for RNA isolation.
Transfection of cultured rat primary neurons was carried out 5 days
post-plating with NRF-2 shRNA constructs (2 μg) or the pLKO.1 non-
mammalian control (2 μg) by means of Neurofect transfection reagent
in 6-well plates according to themanufacturer's instructions (Genlantis,
San Diego, CA). TurboGFP (0.5 μg) vector was added to each well for
transfection visualization and selection efﬁciency. Transfection efﬁciency
was around 40–50% before selection. Puromycin selection, however, ef-
fectively yielded 100% transfected cells. KCl stimulation was performed
on rat visual cortical neurons as described for N2a cells above.
2.8. NRF-2 over-expression and TTX treatment
Vectors expressing human NRF-2α and NRF-2β subunits were used
as described previously [18]. Primers used are shown in Table 4. The
empty pcDNA3.1 vector was used as a control. Transfection procedure
for N2a cells and primary neuronal culture was similar to that described
above. Either the NRF-2 over-expression construct (1.5–2 μg) vector, or
the pcDNA3.1 empty vector (1–1.5 μg), and turboGFP (0.5 μg) vectors
were used, plus 5 μl of JetPrime transfection reagent per well. Green
ﬂuorescence was used to monitor transfection efﬁciency. Transfected
neurons were impulse blocked for 3 days with TTX at a ﬁnal concentra-
tion of 0.4 μM, starting the day after plating as previously described [22].
Four days after transfection, the cells were harvested for RNA isolation.
2.9. RNA isolation and cDNA synthesis
Total RNA was isolated using TRIzol (Invitrogen) according to the
manufacturer's instructions. 1 μg of total RNA was treated with DNase
I and the reaction stopped with heating at 65 °C in the presence
of EDTA. cDNA was synthesized using iScript cDNA synthesis kit (170-
8891, BioRad, Hercules, CA, USA) according to the manufacturer's
instructions.
2.10. Real-time quantitative PCR
Real-time quantitative PCR was carried out in a Cepheid Smart
Cycler Detection system (Cepheid, Sunnyvale, CA, USA) and/or the
iCycler System (BioRad) using the IQ Sybr Green SuperMix (170-8880,
Table 4
NRF-2α and NRF-2β cloning primers.
Gene Primer
NRF-2α F: 5′ AAGCTTACTCCAGCCATGACTAAAAG3′
R: 5′ GGTACCAGCTATACTTGCTCTAAACAT3′
NRF-2β F: 5′ TTGCGGCCGCGATGTCCCTGGTAGATTTG 3′
R: 5′ AAGGATCCTTAAACAGCTTCTTTATTAGTC 3′
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ously [22]. The primer sequences used are shown in Table 5. Primers
were optimized to yield 95%–105% reaction efﬁciency with PCR prod-
ucts run on agarose gel to verify correct ampliﬁcation length. Melt
curve analyses veriﬁed the formation of single desired PCR product in
each PCR reaction. The 2−ΔΔCTmethodwas used to quantify the relative
amount of transcripts [23].
2.11. Western blot analysis
Control, NRF-2 shRNA and over-expression samples were harvested
in RIPA buffer (150 mM sodium chloride, 1.0% NP-40, 0.5% sodium
deoxycholate, 0.1% sodium dodecyl sulfate, 50 mM Tris, pH 8.0) with a
protease inhibitor cocktail (Protease Inhibitor Cocktail III, Research
Products International Corp. (RPI), Mount Prospect, IL, USA) added
just before use. Samples were loaded onto 10% SDS-PAGE gel and pro-
tein was electrophoretically transferred onto polyvinylidene diﬂuoride
membranes (Bio-Rad). Subsequent to blocking, blots were incubated
in primary antibodies against NRF-2α (H-180, 1:1000, SantaCruz Bio-
technology), NRF-2β (gift of Dr. Richard Scarpulla), GluA1 (1:500;
Ab1504, Millipore Chemicon, Billerica, MA, USA), GluA2 (1:200;
75-002 clone L21/32, UC Davis/NIH NeuroMab Facility, Davis, CA,
USA), GluA3 (1:50; sc-7613, Santa Cruz), and GluA4 (1:50; sc-7614,
Santa Cruz). β-actin (1:3000; Sigma) served as loading control. Second-
ary antibodies used were goat-anti-rabbit and goat-anti-mouse anti-
bodies (Vector Laboratories, Burlingame, CA, USA). Blots were then
reacted with ECL reagent (Pierce, Rockford, IL, USA) and exposed to au-
toradiographic ﬁlm (RPI). Quantitative analyses of relative changes
were done with an Alpha Imager (Alpha Innotech, San Leandro, CA,
USA).
2.12. Statistical analysis
Signiﬁcance among group means was determined by analysis of
variance (ANOVA). Signiﬁcance between two groups was analyzed by
Student's t-test. P-values of 0.05 or less were considered signiﬁcant.Table 5
Real time primers.
Gene Primer
Gria1 F: 5′ GAGCAACGAAAGCCCTGTGA 3′
R: 5′ CCCTTGGGTGTCGCAATG 3′
Gria2 F: 5′ AAAGAATACCCTGGAGCACAC 3′
R: 5′ CCAAACAATCTCCTGCATTTCC 3′
Gria3 F: 5′ TTCGGAAGTCCAAGGGAAAGT 3′
R: 5′ CACGGCTTTCTCTGCTCAATG 3′
Gria4 F: 5′ GGCTCGTGTCCGCAAGTC 3′
R: 5′ TTCGCTGCTCAATGTATTCATTC 3′
COX7c F: 5′ ATGTTGGGCCAGAGTATCCG 3′
R: 5′ ACCCAGATCCAAAGTACACGG 3′
NRF2-α F: 5′ CTCCCGCTACACCGACTAC 3′
R: 5′ TCTGACCATTGTTTCCTGTTCTG 3′
NRF2-β F: 5′ ACCAACCAGTGGGATGGGTCAG 3′
R: 5′ GCACATTCCACCCGGCTCTCAAT 3′
Actb F: 5′ GTGACGTTGACATCCGTAAAGA 3′
R: 5′ GCCGGACTCATCGTACTCC 3′
Gapdh F: 5′ AGGTCGGTGTGAACGGATTTG 3′
R: 5′ GGGGTCGTTGATGGCAACA 3′3. Results
3.1. In silico promoter analysis of AMPA receptor subunit genes
NRF-2 binds to the ‘GGAA’ cis motif, or its complement, the ‘TTCC’
motif, in a tandem repeat. In silico analysis of the proximal pro-
moters of murine AMPA receptor subunit genes in the DNA sequence
1 kb upstream and 1 kb downstream of the transcription start
site (TSP) revealed a tandem repeat of the NRF-2 binding motifs
(separated by up to 24 bp) on all subunit genes (see Table 1A for
binding motifs).
3.2. In vitro binding of NRF-2 to AMPA receptor subunit promoters
To determine if NRF-2 was able to bind to putative binding sites on
the AMPA promoters in vitro, the EMSA and supershift assayswere per-
formed. Murine cytochrome c oxidase subunit 6b (COX6b) promoter,
with a known NRF-2 binding site, served as the positive control [19].
When incubated with N2a nuclear extract, COX6b formed speciﬁc
DNA/NRF-2 shift and supershift complexes (Fig. 1, lanes 1 and 3,
respectively). When an excess of unlabeled COX6b probe was added as
a competitor, no shift band was formed (Fig. 1, lane 2).
When AMPA receptor subunit gene promoters were tested for
NRF-2 binding, only Gria1 and Gria2 gave positive NRF-2 shift
(Fig. 1, lanes 4 and 9, respectively) and supershift bands (Fig. 1,
lanes 6 and 11, respectively). Signiﬁcantly, NRF-2 bound more
strongly to the Gria2 probe than to the Gria1 probe, even though
the same amount of radioactive probe was used for each reaction.
The addition of unlabeled probes competed out the shift band for
both Gria1 and Gria2 (Fig. 1, lanes 5 and 10, respectively), whereas
the addition of unlabeled probes with mutated NRF-2 binding site
did not compete out the speciﬁc shift bands for either gene (Fig. 1,
lanes 7 and 12, respectively). Labeled probes with mutant NRF-2
sites on Gria1 and Gria2 did not form speciﬁc shift or NRF-2
supershift bands when incubated with N2a nuclear extract and/or
NRF-2 antibody (Fig. 1, lanes 14–17, respectively). In the absence of
N2a nuclear extract, NRF-2 antibody did not bind to labeled Gria1
and Gria2 probes (Fig. 1, lanes 8 and 13 respectively). Labeled Gria3
and Gria4 probes incubated with N2a extract and/or NRF-2 antibody
did not reveal speciﬁc shift or supershift bands (data not shown).
3.3. In vivo interaction of NRF-2 with AMPA receptor subunit genes in N2a
cells
The ChIP assay was performed to verify NRF-2 protein interaction
with AMPA receptor subunit gene promoters in vivo. Sonicated nu-
clear lysates from N2a cells were immunoprecipitated with NRF-2
antibody and the resulting DNA was subjected to PCR analysis
using primers that encompassed the putative NRF-2 binding site
identiﬁed by in silico analysis. Immunoprecipitation with nerve
growth factor receptor (NGFR) antibody and “no antibody” served
as negative controls. As NRF-2 regulates COX6b, primers against the
COX6b gene promoter were used as a positive control for the immu-
noprecipitation [19]. Exon 8 of NRF-1, a region of DNA that does not
contain a NRF-2 binding site, was used as a negative control. 0.5% and
0.1% input DNA were used as positive control for the PCR reaction.
Determination of NRF-2 binding to promoter regions was done by
parallel PCR ampliﬁcation of all controls and immunoprecipitated
samples.
As seen in Fig. 2A, agarose gel analysis of PCR products revealed spe-
ciﬁc bands for input controls in all the tested regions of the proximal
AMPA receptor subunit gene promoters. The NRF-2 immunoprecipitated
sample revealed an enriched band for COX6b positive control and Gria2,
but not for the negative control, exon 8 of NRF-1. An enriched band did
not occur in the NGFR or “no antibody” negative controls. There was
Fig. 1. In vitro binding of NRF-2 to putative binding sites on the AMPA receptor subunit gene promoters as determined with EMSA and supershift assays. 32P-labeled oligonucleotides,
excess unlabeled oligos as competitors, excess unlabeled mutant NRF-2 oligos as competitors, N2a nuclear extract, and NRF-2α antibodies are indicated by a+ or a− sign. Arrowheads
indicate speciﬁc NRF-2 shift, supershift, and non-speciﬁc complexes. The positive control, COX6b, shows a shift and supershift band (lanes 1 and 3, respectively). The addition of excess
unlabeled probe competed out the shift band (lane 2). The addition of N2a nuclear extract yielded speciﬁc shift bands for both Gria1 and Gria2 (lanes 4 and 9, respectively) that were com-
peted out by an excess of unlabeled oligos (lanes 5 and 10, respectively). The addition of NRF-2 antibody yielded a supershift band for both Gria1 and Gria2 (lanes 6 and 11, respectively).
The addition of excess unlabeled probes withmutated NRF-2 binding sites did not compete out the shift reaction (lanes 7 and 12, respectively). The addition of NRF-2 antibody to labeled
Gria1 and Gria2 probes in the absence of N2a extract did not reveal any antibody-to-probe reaction (lanes 8 and 13, respectively). LabeledGria1 and Gria2 probeswithmutatedNRF-2 sites
did not yield a speciﬁc NRF-2 shift band (lanes 14 and 16, respectively), nor a supershift band with the addition of NRF-2 antibody (lanes 15 and 17, respectively).
Fig. 2. In vivo interaction of NRF-2 with the AMPA receptor subunit gene promoters using the ChIP assay in N2a cells (A) and murine visual cortical tissue (B). Nuclear extract was
immunoprecipitated with anti NRF-2α antibodies (NRF-2 IP lane), anti-nerve growth factor receptor p75 antibody (negative control, NGFR IP lane), or no antibody (negative control,
No Ab lane). Control reactions for PCR were performed with 0.5% (Input 0.5% IP lane) and 0.1% (Input 0.1% IP lane) of input chromatin. COX6B promoter was used as a positive control,
and Exon 8 of NRF-1 was used as a negative control. Results indicate NRF-2 interactions with the tested region on the Gria2 promoter, but not the Gria1, Gria3, or Gria4 promoters, in
both N2a cells and murine visual cortical tissue.
3022 A. Priya et al. / Biochimica et Biophysica Acta 1843 (2014) 3018–3028
3023A. Priya et al. / Biochimica et Biophysica Acta 1843 (2014) 3018–3028also no enrichment of DNA in the NRF-2 immunoprecipitated samples
for Gria1, Gria3, and Gria4.
3.4. In vivo interaction of NRF-2 with AMPA receptor subunit genes in
murine visual cortex
To verify the lack of NRF-2 binding to Gria1was not exclusive to N2a
cells, ChIP assays were also performed with sonicated nuclear extract
from visual cortical tissue of wild type C6BL/J6 mice. Immunoprecipita-
tion with NRF-2 antibody, as well as the positive and negative controls
for the reaction, was similar to those of ChIP assays performed with
N2a cell nuclear lysate described above.
As seen in Fig. 2B, agarose gel analysis of PCR products revealed
speciﬁc bands for input controls in all the tested regions of the AMPA re-
ceptor subunit gene promoters. The NRF-2 immunoprecipitated sample
revealed an enriched band for COX6b positive control and for Gria2, but
not for exon 8 of NRF-1 negative control. An enriched band did not
occur in theNGFR or “no antibody”negative controls in any of the tested
DNA regions. There was also no enrichment of DNA in the NRF-2
immunoprecipitated samples for Gria1, Gria3, and Gria4.
3.5. Effect of mutated NRF-2 binding sites on the Gria2 and COX6b
promoters
The proximal promoter region of Gria2 was cloned into the pGL3
basic luciferase vector and site-directed mutagenesis of its NRF-2 tan-
dem binding site was performed. Transfection of wild type or mutated
Gria2 promoter into N2a cells revealed a signiﬁcant 66% decrease in pro-
moter activity of the Gria2 promoter containing the mutated NRF-2
motif (P b 0.001, Fig. 3). The COX6b promoter was used as a positive
control [19]. The COX6b promoter containing a mutated NRF-2 motif
showed a signiﬁcant decrease in promoter activity (P b 0.001, Fig. 3).
3.6. Effect of mutated NRF-2 binding sites on the response of the Gria2
promoter to KCl stimulation
Wehave shownpreviously that theGria2 promoter is up-regulated by
KCl-stimulated increase in neuronal activity [13]. To verify that NRF-2
binding is necessary for this up-regulation, the control Gria2 promoter
or the Gria2 promoter withmutated putative NRF-2 site were transfected
into N2a cells. As shown in Fig. 3, N2a cells transfected with the control
Gria2 promoter and subjected to KCl depolarizing stimulation exhibited
a 147% increase in promoter activity (P b 0.001). This increase
was abolished by mutating the NRF-2 binding site (Fig. 3), conﬁrming a
requirement for NRF-2 binding in the KCl depolarization-induced up-
regulation of the Gria2 promoter.Fig. 3. Site-directedmutational analysis of promoters using luciferase reporter gene constructs.W
Gria2 are indicated. COX6b served as a positive control.Mutating theNRF-2 site resulted in a sign
the NRF-2 binding sites on theGria2 promoter resulted in signiﬁcant decreases in luciferase acti
the COX6b and Gria2 promoters with mutated NRF-2 sites. N= 6 for each construct. *** = P b 0
+ KCl are compared to mutants.3.7. Effect of silencing NRF-2 by RNA interference on AMPA receptor
subunits in N2a cells
To determine the effect of silencing NRF-2α transcript on the ex-
pression of AMPA receptor subunits, two shRNA plasmid vectors
targeting NRF-2α mRNA were used. These vectors were previously
found to silence NRF-2α expression in N2a cells [18]. The pBS/U6
empty vector was used as a control. Quantitative real-time PCR and
the 2−ΔΔCT method were used to quantify relative NRF-2α and AMPA
receptor subunitmRNA levels,with silencedNRF-2α samples compared
against control samples. Gapdhwas used as the internal control. Silenc-
ing of NRF-2α resulted in a 58% decrease in levels of NRF-2α mRNA
(P b 0.001, Fig. 4B). Therewas a signiﬁcant 39% decrease inmRNA levels
of the positive control COX7c [18], and a signiﬁcant 28% decrease in
mRNA levels of Gria2 (P b 0.001 and P b 0.01, respectively, Fig. 4B). Pro-
tein levels of NRF-2α decreased signiﬁcantly by 51% (P b 0.001, Fig. 4A).
Protein levels of GluA2 decreased signiﬁcantly by 25% (P b 0.05, Fig. 4A).
mRNA and protein levels of Gria1 (Fig. 4B and A, respectively) were not
signiﬁcantly changed, and neither were the mRNA and protein levels of
Gria3 and Gria4 (Fig. 4B and Supplemental Fig. 1).
3.8. Effect of over-expressing NRF-2 on AMPA receptor subunits in N2a cells
As the functional NRF-2 transcription factor requires the DNA-
binding of the α subunit as well as the transactivating β subunit,
vectors over-expressing both NRF-2α and β subunits were co-
transfected into N2a cells. The pcDNA3.1 empty vector was used as a
control. β-actin was used as the internal control. Over-expression of
NRF-2α andβ resulted in anapproximately 30-fold and 15-fold increase
in NRF-2α and β subunit transcripts, respectively (P b 0.001 for both,
Fig. 5B), and a 3.5-fold and 4.25-fold increases in their protein levels, re-
spectively (P b 0.001 for both, Fig. 5A). Transcript levels of the positive
control, COX7c, increased 145.5% with NRF-2 over-expression
(P b 0.01, Fig. 5C). Gria2mRNA and protein levels also increased signif-
icantly with NRF-2 over-expression to 163% and 175%, respectively
(P b 0.001 for both, Fig. 5B and C, respectively). mRNA levels of Gria1,
Gria3, and Gria4 did not change signiﬁcantly with over-expression
(Fig. 5C), nor did protein levels of GluA1, GluA3, and GluA4 (Fig. 5C
and Supplemental Fig. 1).
3.9. Silencing NRF-2 abolished KCl-induced transcript up-regulation of
Gria2 in N2a cells
We have previously shown that GluA2 transcript and protein levels
are up-regulated in response to KCl [13]. To see if the up-regulation of
Gria2 transcript level is dependent on NRF-2 function, N2a cellsild type promoters (wt) and thosewithmutated NRF-2 binding site (mut) for COX6b and
iﬁcant decrease in the luciferase activity as compared to thewild type. Similarly, mutating
vity. KCl depolarization signiﬁcantly increased promoter activity in all wild type, but not in
.001; X= NS. All mutants and wild type + KCl are compared to the wild type. All mutant
Fig. 4. Effect of RNA interference-mediated silencing of NRF-2α on the expression of COX and AMPA receptor subunit genes. (A)Western blots revealed a down-regulation of NRF-2α and
GluA2 protein levels (lane 2) as compared to controls (lane 1), but not GluA1 protein levels, in NRF-2α shRNA-transfected cells. β-actin served as a loading control. N = 3 for each data
point; *** = P b 0.001 and * = P b 0.05 when compared to pBS/U6 empty vector controls. (B) As determined by real-time PCR, NRF-2α shRNA transfection in N2a cells down-regulated
mRNA levels of NRF-2α and Gria2, but not those ofGria1, Gria3, and Gria4. mRNA levels of the positive control, COX7c, were also reducedwith NRF-2α silencing. N=6 for each data point.
*** = P b 0.001 and ** = P b 0.01 when compared to pBS/U6 empty vector controls.
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against NRF-2 were subjected to 5 h of 20mMKCl. Depolarizing stimuli
resulted in a 212% increase in Gria2 transcript levels (P b 0.001, Fig. 6A)
that failed to increase in the presence of NRF-2 shRNA. Transcript levels
of COX7c positive controls increased signiﬁcantly (142%, P b 0.001,
Fig. 6A) with KCl depolarization, but was abolished with shRNA treat-
ment. Transcript levels of Gria1, Gria3, and Gria4 increased signiﬁcantly
with KCl treatment (P b 0.001 for all, Fig. 6A) that remained as such in
the presence of NRF-2 shRNA treatment (Fig. 6A).3.10. Over-expression of NRF-2 rescued tetrodotoxin-induced transcript
reduction of Gria2 in N2a cells
Our lab has previously shown that reducing neuronal activity
with 0.4 μM TTX treatment also decreases transcript levels of COX
and Gria2 [13,18]. To determine if NRF-2 over-expression can rescue
the down-regulation of COX and Gria2 induced by TTX, vectors ex-
pressing NRF-2α and β subunits were transfected into N2a cells
that were later subjected to 0.4 μM TTX treatment for 3 days. As
expected, COX7c and Gria2 mRNA levels decreased to 66% and 55%,
respectively (P b 0.001 for both, Fig. 6B). The cells transfected with
NRF-2α and β rescued the down-regulation seen with TTX treat-
ment, with an increase of 132% and 146%, respectively, as compared
to the pcDNA3.1 empty vector controls (P b 0.001 for both, as
compared to TTX alone; Fig. 6B). Transcript levels of Gria1, Gria3,
and Gria4 also decreased with TTX treatment but were not rescued
by an over-expression of NRF-2α/β (Fig. 6B).3.11. Effect of silencing NRF-2 by RNA interference on AMPA receptor
subunits in primary neurons
To determine if the effect seen with NRF-2 shRNA was restricted to
N2a cells, primary cultured neurons were transfected with the same
shRNA, andGapdh served as the internal control. NRF-2 silencing result-
ed in a 58% decrease in its mRNA levels (P b 0.01, Fig. 7A). Gria2's
transcript levels were also decreased signiﬁcantly by 48% (P b 0.05;
Fig. 7A). However, Gria1, Gria3, and Gria4 transcripts were not changed
signiﬁcantly with NRF-2 silencing (Fig. 7A).
3.12. Silencing NRF-2 abolished KCl-induced transcript up-regulation of
Gria2 in primary neurons
Depolarizing stimulation with 20 mM KCl for 5 h signiﬁcantly in-
creasedmRNA levels of NRF-2,Gria1, Gria2, Gria3, andGria4 in rat visual
cortical neurons (P b 0.01–0.05; Fig. 7A). However, when neurons were
transfected with NRF-2 shRNA and stimulated with KCl, NRF-2 and
Gria2 transcripts were signiﬁcantly down-regulated to 84% and 50%,
respectively (P b 0.001 for both; Fig. 7A), whereas those of Gria1,
Gria3, and Gria4were not affected (Fig. 7A).
3.13. Effect of over-expressingNRF-2 onAMPA receptor subunits in primary
neurons
To verify that the effect of over-expressing NRF-2 was not restricted
to N2a cells, cultured rat cortical neuronswere transfectedwith NRF-2α
Fig. 5. Effect of over-expressing NRF-2α and β on the transcript and protein levels of COX7c and AMPA receptor subunit genes. (A) NRF-2α/β over-expression increased protein levels of
NRF-2α and NRF-2β, as well as GluA2 (lane 2) as compared to controls (lane 1). Protein levels of GluA1 did not increase signiﬁcantly with NRF-2α/β over-expression. β-actin served as a
loading control. N= 3 for each data point; ***= P b 0.001when compared to pcDNA3.1 empty vector controls. (B) Real-time PCR revealed an up-regulation of NRF-2α and βmRNAwith
NRF-2α/β over-expression as compared to pcDNA3.1 empty vector controls. (C) In N2a cells, mRNA levels ofGria2, but not those ofGria1, Gria3, and Gria4, were increasedwith NRF-2α/β
over-expression. mRNA levels of the positive control, COX7c, were also increased with NRF-2α/β over-expression. N = 6 for each data point. ** = P b 0.01 and *** = P b 0.001 when
compared to pcDNA3.1 empty vector controls.
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over-expression resulted in a 186% increase in its mRNA levels
(P b 0.001, Fig. 7B). Gria2 mRNA levels also increased signiﬁcantly by
174% with NRF-2 over-expression (P b 0.001; Fig. 7B). However, Gria1,
Gria3, and Gria4mRNA levels were not changed signiﬁcantly (Fig. 7B).
3.14. Over-expression of NRF-2 rescued tetrodotoxin-induced transcript
reduction of Gria2 in primary neurons
Transcript levels of NRF-2, Gria1, Gria2, Gria3, and Gria4 in rat
visual cortical neurons were all signiﬁcantly down-regulated by
0.4 μM TTX-treatment for 3 days (P b 0.001–0.01; Fig. 7B). NRF-2
over-expression rescued NRF-2 and Gria2 transcripts from being
down-regulated by TTX (P b 0.001 for both, as compared to TTX
alone), but had no effect on those of Gria1, Gria3, and Gria4 (Fig. 7B).
3.15. Homology of NRF-2 binding sites
The functional NRF-2 binding site on the Gria2 promoter is
conserved among mice, rats, and humans (Fig. 8).
4. Discussion
Using multiple approaches, including EMSA and supershift assays,
ChIP in primary visual cortical tissue, promoter mutational analysis,
over-expression and silencing studies, the present study documents
for the ﬁrst time that nuclear respiratory factor 2 (NRF-2) functionally
regulates the expression of the AMPA receptor subunit Gria2 (GluA2),
but notGria1 (GluA1),Gria3 (GluA3), orGria4 (GluA4) genes.Moreover,
silencing of NRF-2 prevented the up-regulation of Gria2 mRNA levelsinduced by depolarizing stimulation, whereas over-expression of NRF-
2 rescued mRNA levels suppressed by TTX-induced impulse blockade.
The NRF-2 regulatory site in the Gria2 promoter is conserved among
mice, rats, and humans.
It is important to note that even though NRF-2 binds toGria1 in vitro
(EMSA), it does not do so in vivo (ChIP). EMSA is helpful as an initial
ﬁrst step in testing for possible binding site of transcription factors.
However, the relatively short oligonucleotides are not in the context
of a natural, cellular environment. The in vivo ChIP assay is necessary
to conﬁrm (or refute) that the binding is physiological. The additional
functional and gene perturbation studies are also necessary to validate
the functional signiﬁcance of NRF-2's regulation of Gria2, and not of
the other AMPA subunit genes.
AMPA receptors are among the most prevalent excitatory gluta-
matergic receptors in the brain. The majority of heterotetrameric
AMPA receptors in the adult cortex and hippocampus contain the
GluA2 subunit in combination with either the GluA1 or the GluA3 sub-
unit [6,7,24]. The expression of GluA3 is lower than that of GluA1, and
GluA1/GluA2 receptors aremore prevalent than GluA2/GluA3 receptors
in the adult cortex and hippocampus [6,7,25]. The GluA4 subunit is de-
velopmentally expressed and complexes with GluA2 in the immature
hippocampus [9]. The presence or absence of GluA2 determines the
major physiological properties of the AMPA receptor, including its ki-
netics, ion permeability, and conductance. GluA2 is unique among the
AMPA subunits in that it undergoes hydrolytic editing of its pre-mRNA
[26]. This editing converts a glutamine to an arginine in GluA2's critical
pore-forming region and renders GluA2-containing receptors less
permeable to Ca2+ [26–28]. GluA2-containing receptors are inwardly
rectifying and exhibit low single channel conductance as compared to
those that do not contain GluA2 subunits [24,29–31]. The presence or
Fig. 6.Effect of KCl or TTX treatment in thepresenceofNRF-2 silencingor over-expression,
respectively, on the transcript levels of the AMPA receptor subunit genes and COX7c in
N2a cells. (A) Cells treated for 5 h with 20 mM KCl revealed an up-regulation of all tran-
scripts as compared to pBS/U6 empty vector controls. In the presence of shRNA against
NRF-2α, 5 h treatment with 20 mM KCl failed to up-regulate the transcripts of Gria2
and COX7c, but it did up-regulate those of Gria1, Gria3, and Gria4. (B) N2a cells treated
for 3 days with 0.4 μM TTX revealed a down-regulation of all tested transcripts as com-
pared to pcDNA3.1 empty vector controls. Over-expression of NRF-2α and β rescued
the down-regulation of the COX7c and Gria2 transcripts, but not those of Gria1, Gria3,
and Gria4. N = 6 for each data point; *** = P b 0.001 when compared to controls;
### = P b 0.001 and X = non-signiﬁcant when compared to KCl- or TTX-treated
samples.
Fig. 7. Effect of NRF-2 silencing and over-expression, with and without KCl or TTX treat-
ment, respectively, on the transcript levels of the AMPA receptor subunit genes in visual
cortical neurons. (A) NRF-2α shRNA transfection in primary neurons down-regulated
mRNA levels of NRF-2α andGria2, but not those of Gria1, Gria3, and Gria4. Primary neurons
treated for 5 h with 20 mM KCl revealed an up-regulation of all transcripts as compared to
pBS/U6 empty vector controls. In the presence of shRNA against NRF-2α, 5 h treatment
with 20 mM KCl did not up-regulate transcripts of NRF-2α and Gria2, but it did up-regulate
those of Gria1, Gria3, and Gria4. N= 3 for each data point. ***= P b 0.001, **= P b 0.01 and
* = P b 0.05 when compared to pBS/U6 empty vector controls. ###= P b 0.001 and X =
non-signiﬁcant when compared to KCl-treated samples. (B) In primary neurons, NRF-2α/β
over-expression led to an increase in the transcript levels of NRF2α andGria2, but not those
of Gria1, Gria3, and Gria4. Primary neurons treated for 3 days with 0.4 μM TTX revealed a
down-regulation of all tested transcripts as compared to pcDNA3.1 empty vector controls.
Over-expression of NRF-2α and β rescued the down-regulation of Gria2 transcripts,
but not those of Gria1, Gria3, and Gria4. N = 3 for each data point; *** = P b 0.001 and
** = P b 0.01 when compared to controls; ### = P b 0.001 and X = non-signiﬁcant
when compared to TTX-treated samples.
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properties of the AMPA receptor to the same extent as the presence or
absence of GluA2.
GluA2 knockout mice exhibit multiple behavioral abnormalities, in-
cluding deﬁcits in object exploration, grooming, eye-closure reﬂex, and
spatial and non-spatial learning [32]. Amechanism for themaintenance
of long-term potentiation (LTP), the prototypical form of synaptic
plasticity thought to underlie information storage and experience-
dependent plasticity, can be through an increase in GluA2-containing
receptors at hippocampal synapses [33–35]. In some regions of the
brain, another form of synaptic plasticity, long-term depression (LTD),
is thought to require the GluA2 subunit [36,37]. Thus, the GluA2 subunit
is important for normal neuronal activities including synaptic plasticity,
learning, and memory.
The GluA2 subunit responds to changes in neuronal activity. Our
laboratory has shown that both transcript and protein expressions of
GluA2 in cultured visual cortical neurons are up-regulated by physiolog-
ical concentrations of KCl [38]. Likewise, TTX-induced impulse blockade
leads to a down-regulation of GluA2 mRNA and protein levels [38].
Furthermore, concurrent with neuronal activity-mediated changes in
GluA2 transcript and protein levels is a parallel change in protein
and transcript levels of cytochrome c oxidase (COX), a critical enzyme
for energy generation in neurons [38]. In the supragranular andinfragranular layers of the macaque visual cortex, GluA2 levels are
governed by visual input and neuronal activity [39]. Monocular impulse
blockade induces a down-regulation of GluA2 in deprived ocular domi-
nance columns, where the activity level of COX is also reduced [39].
Thus, GluA2 and COX are tightly regulated at the cellular level. As the
bulk of energy in neurons is used for repolarizing membrane potentials
after excitatory depolarization [10,11], the level of GluA2 will affect the
level of neuronal activity, hence, the energy demand of neurons.
The current study shows that amolecularmechanism for theparallel
regulation of COX and Gria2 is through nuclear respiratory factor 2
(NRF-2), an Ets family transcription factor that is the human homologue
of the murine GA binding protein (GABP) (for review see [40]). The
functional NRF-2 protein is a heterodimer or a heterotetramer of the α
and β subunits [41]. The α subunit contains the DNA binding domain
that binds to the GGAA cis-element [41,42]. The β subunit contains
the transactivating domain and mediates heterodimer (αβ) or
heterotetramer (α2β2) formation, the latter being induced by
homodimerization of two β subunits [42,43]. With increased neuronal
activity, NRF-2α and β levels are up-regulatedwith a nuclear transloca-
tion of the subunits [44–46]. Our previous studies have shown that NRF-
Fig. 8. Aligned partial sequences of Gria2 promoter from mouse, rat, and human showed conservation of the NRF-2 binding site.
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and energy metabolism by regulating critical subunits of the excitatory
glutamatergic NMDA receptors [18–20].
Previously, we have shown that the expression of the GluA2 subunit
is also regulated by nuclear respiratory factor 1 (NRF-1) and speciﬁcity
protein 4 (Sp4), transcription factors that regulate all 13 subunits of COX
[12–14,16]. Thus, the mechanism employed by NRF-2 with respect to
NRF-1 and Sp4 in regulating the GluA2, but not GluA1, GluA3, or
GluA4 subunits, is the concurrent and parallel mechanism rather than
the complementary one.
It has recently been shown that excessive activation of AMPA recep-
tors by glutamate is involved in neuronal excitotoxicity [47,48]. In
diseases such as amyotrophic lateral sclerosis and ischemia, activation
of AMPA receptors can lead to excitotoxic cell death [47,49,50]. The
entry of excessive Ca2+ ions often triggers excitotoxic neuronal damage,
and Ca2+ permeable AMPA receptors play an important role in AMPA
receptor-mediated excitotoxicity [47–50]. Incorporation of the GluA2
subunit, however, substantially reduces the Ca2+ permeability of the
AMPA receptor [28]. The current work, as well as past studies by this
laboratory, shows that GluA2 mRNA and protein levels are coupled to
neuronal activity at the transcriptional level [13,14,18,19]. The concur-
rent and parallel mechanism of transcriptional coupling of the GluA2
subunit with energy metabolism by NRF-1, NRF-2, and Sp4 may be a
mechanism by which neurons can limit the entry of Ca2+ ions under
conditions of increased neuronal activity and protect them from poten-
tial damage caused by Ca2+-induced excitotoxicity.
Although NRF-1, NRF-2, and Sp4 co-regulate GluA2 via a concurrent
and parallel mechanism, it is unlikely that they function in a redundant
manner. First, knockout of either NRF-1 or NRF-2 is embryonically
lethal, and silencing of one does not affect the expression of the other
[14,18]. While knockout of Sp4 is not lethal, the neurological deﬁcits
seen with a lack of Sp4 were not compensated for by any other tran-
scription factor [51,52]. Second, a virtually identical pattern of COX ac-
tivity and NRF-2α expression exists in the macaque visual cortex,
under both normal and functionally perturbed states [45,53,54]. Such
was not the case for NRF-1 (our unpublished observations). Third,
both NRF-1 and NRF-2 interact with peroxisome proliferator-activated
receptor-γ coactivator 1α (PGC-1α) to co-operatively enhance the
transcription of target genes [55]. PGC-1α is a transcriptional co-
activator regulated by neuronal activity, and it potently induces mRNA
and protein expressions of NRF-1 and NRF-2 [55–57]. However, where-
as PGC-1α interacts directlywithNRF-1, it does so indirectlywithNRF-2
through a co-regulator, host cell factor 1 (HCF-1) [55,58]. Direct interac-
tion of PGC-1α with Sp4 is not reported, but Sp1, a transcription factor
in the same family as Sp4, is known to interact with HCF-1 [59]. The
presence of an intermediate in the PGC-1α and NRF-2 interaction, as
well as a possible intermediate in the PGC-1α and Sp4 interaction,
suggests that NRF-1, NRF-2, and Sp4 operate slightly differently in the
co-regulation of neuronal activity and energy metabolism. Elucidating
themechanisms of such regulation will help to further our understand-
ing of the differential and non-redundant roles played by these
transcription factors in neurons.
We have previously shown that genes of all nucleus-encoded
subunits of COX and that of Gria2 (as well as of NMDA receptors) are
transcribed in close physical proximity, i.e., in the same transcription
factory within the nucleus [60]. NRF-2, NRF-1, and Sp4's concurrent
and parallel mechanism of regulation makes it likely that thetranscription factors exist within the same transcription factory to
regulate gene expression, at least at the basal level, in neurons. Chromo-
somal interactions are also affected by changes in neuronal activity [60].
The fact that NRF-2 (the present study), NRF-1 [13], and Sp4 [61] re-
spond to such changes themselves suggests that their regulation in neu-
rons is highly dynamic.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamcr.2014.09.006.
Acknowledgments
This work is supported by NIH grant R01 EY018441 and NIH/NEI
training grant 1-T32-EY14537. Anusha Priya is a member of the
MCW-MSTP, which is partially supported by a T32 grant from NIGMS,
GM080202.
References
[1] J.T. Isaac, M.C. Ashby, C.J. McBain, The role of the GluR2 subunit in AMPA receptor
function and synaptic plasticity, Neuron 54 (2007) 859–871.
[2] R. Malinow, R.C. Malenka, AMPA receptor trafﬁcking and synaptic plasticity, Annu.
Rev. Neurosci. 25 (2002) 103–126.
[3] G.G. Turrigiano, The self-tuning neuron: synaptic scaling of excitatory synapses, Cell
135 (2008) 422–435.
[4] J.D. Shepherd, R.L. Huganir, The cell biology of synaptic plasticity: AMPA receptor
trafﬁcking, Annu. Rev. Cell Dev. Biol. 23 (2007) 613–643.
[5] K. Borges, R. Dingledine, AMPA receptors: molecular and functional diversity, Prog.
Brain Res. 116 (1998) 153–170.
[6] R.J. Wenthold, R.S. Petralia, J. Blahos II, A.S. Niedzielski, Evidence for multiple AMPA
receptor complexes in hippocampal CA1/CA2 neurons, J. Neurosci. 16 (1996)
1982–1989.
[7] A.M. Craig, C.D. Blackstone, R.L. Huganir, G. Banker, The distribution of glutamate
receptors in cultured rat hippocampal neurons: postsynaptic clustering of AMPA-
selective subunits, Neuron 10 (1993) 1055–1068.
[8] R.S. Petralia, R.J. Wenthold, Light and electron immunocytochemical localization of
AMPA-selective glutamate receptors in the rat brain, J. Comp. Neurol. 318 (1992)
329–354.
[9] J.J. Zhu, J.A. Esteban, Y. Hayashi, R.Malinow, Postnatal synaptic potentiation: delivery
of GluR4-containing AMPA receptors by spontaneous activity, Nat. Neurosci. 3
(2000) 1098–1106.
[10] M.T. Wong-Riley, Bigenomic regulation of cytochrome C oxidase in neurons and the
tight coupling between neuronal activity and energy metabolism, Adv. Exp. Med.
Biol. 748 (2012) 283–304.
[11] M.T.Wong-Riley, Cytochrome oxidase: an endogenousmetabolicmarker for neuronal
activity, Trends Neurosci. 12 (1989) 94–101.
[12] A. Priya, K. Johar, B. Nair, M.T. Wong-Riley, Speciﬁcity protein 4 (Sp4) regulates the
transcription of AMPA receptor subunit GluA2 (Gria2), Biochim. Biophys. Acta 1843
(2014) 1196–1206.
[13] S.S. Dhar, H.L. Liang, M.T. Wong-Riley, Nuclear respiratory factor 1 co-regulates
AMPA glutamate receptor subunit 2 and cytochrome c oxidase: tight coupling of
glutamatergic transmission and energy metabolism in neurons, J. Neurochem. 108
(2009) 1595–1606.
[14] S.S. Dhar, S. Ongwijitwat, M.T. Wong-Riley, Nuclear respiratory factor 1 regulates all
ten nuclear-encoded subunits of cytochrome c oxidase in neurons, J. Biol. Chem. 283
(2008) 3120–3129.
[15] S.S. Dhar, M.T.Wong-Riley, Coupling of energymetabolism and synaptic transmission
at the transcriptional level: role of nuclear respiratory factor 1 in regulating both
cytochrome c oxidase and NMDA glutamate receptor subunit genes, J. Neurosci. 29
(2009) 483–492.
[16] K. Johar, A. Priya, S. Dhar, Q. Liu, M.T.Wong-Riley, Neuron-speciﬁc speciﬁcity protein
4 bigenomically regulates the transcription of all mitochondria- and nucleus-
encoded cytochrome c oxidase subunit genes in neurons, J. Neurochem. 127
(2013) 496–508.
[17] A. Priya, K. Johar, M.T. Wong-Riley, Speciﬁcity protein 4 functionally regulates the
transcription of NMDA receptor subunits GluN1, GluN2A, and GluN2B, Biochim.
Biophys. Acta 1833 (2013) 2745–2756.
[18] S. Ongwijitwat, H.L. Liang, E.M. Graboyes, M.T. Wong-Riley, Nuclear respiratory
factor 2 senses changing cellular energy demands and its silencing down-regulates
cytochrome oxidase and other target gene mRNAs, Gene 374 (2006) 39–49.
3028 A. Priya et al. / Biochimica et Biophysica Acta 1843 (2014) 3018–3028[19] S. Ongwijitwat, M.T. Wong-Riley, Is nuclear respiratory factor 2 a master transcrip-
tional coordinator for all ten nuclear-encoded cytochrome c oxidase subunits in
neurons? Gene 360 (2005) 65–77.
[20] A. Priya, K. Johar, M.T.Wong-Riley, Nuclear respiratory factor 2 regulates the expres-
sion of the same NMDA receptor subunit genes as NRF-1: both factors act by a
concurrent and parallel mechanism to couple energy metabolism and synaptic
transmission, Biochim. Biophys. Acta 1833 (2013) 48–58.
[21] S.M. Abmayr, T. Yao, T. Parmely, J.L. Workman, Preparation of nuclear and cytoplas-
mic extracts from mammalian cells, Curr. Protoc. Mol. Biol. (2006) (Chapter 12
(2006) Unit 12.1).
[22] S.S. Dhar, H.L. Liang, M.T. Wong-Riley, Transcriptional coupling of synaptic transmis-
sion and energy metabolism: role of nuclear respiratory factor 1 in co-regulating
neuronal nitric oxide synthase and cytochrome c oxidase genes in neurons, Biochim.
Biophys. Acta 1793 (2009) 1604–1613.
[23] K.J. Livak, T.D. Schmittgen, Analysis of relative gene expression data using real-time
quantitative PCR and the 2(-Delta Delta C(T))Method,Methods 25 (2001) 402–408.
[24] J.R. Geiger, T. Melcher, D.S. Koh, B. Sakmann, P.H. Seeburg, P. Jonas, H. Monyer, Rel-
ative abundance of subunit mRNAs determines gating and Ca2+ permeability of
AMPA receptors in principal neurons and interneurons in rat CNS, Neuron 15
(1995) 193–204.
[25] N. Sans, B. Vissel, R.S. Petralia, Y.X. Wang, K. Chang, G.A. Royle, C.Y. Wang, S.
O'Gorman, S.F. Heinemann, R.J. Wenthold, Aberrant formation of glutamate recep-
tor complexes in hippocampal neurons of mice lacking the GluR2 AMPA receptor
subunit, J. Neurosci. 23 (2003) 9367–9373.
[26] B. Sommer, M. Kohler, R. Sprengel, P.H. Seeburg, RNA editing in brain controls a de-
terminant of ion ﬂow in glutamate-gated channels, Cell 67 (1991) 11–19.
[27] M. Higuchi, F.N. Single, M. Kohler, B. Sommer, R. Sprengel, P.H. Seeburg, RNA editing
of AMPA receptor subunit GluR-B: a base-paired intron–exon structure determines
position and efﬁciency, Cell 75 (1993) 1361–1370.
[28] R. Dingledine, K. Borges, D. Bowie, S.F. Traynelis, The glutamate receptor ion chan-
nels, Pharmacol. Rev. 51 (1999) 7–61.
[29] F. Laezza, R. Dingledine, Voltage-controlled plasticity at GluR2-deﬁcient synapses
onto hippocampal interneurons, J. Neurophysiol. 92 (2004) 3575–3581.
[30] S. Hestrin, Different glutamate receptor channels mediate fast excitatory synaptic
currents in inhibitory and excitatory cortical neurons, Neuron11 (1993) 1083–1091.
[31] S.K. Kamboj, G.T. Swanson, S.G. Cull-Candy, Intracellular spermine confers rectiﬁca-
tion on rat calcium-permeable AMPA and kainate receptors, J. Physiol. 486 (Pt 2)
(1995) 297–303.
[32] R. Gerlai, J.T. Henderson, J.C. Roder, Z. Jia, Multiple behavioral anomalies in GluR2
mutant mice exhibiting enhanced LTP, Behav. Brain Res. 95 (1998) 37–45.
[33] S.Q. Liu, S.G. Cull-Candy, Synaptic activity at calcium-permeable AMPA receptors in-
duces a switch in receptor subtype, Nature 405 (2000) 454–458.
[34] S.J. Liu, S.G. Cull-Candy, Activity-dependent change in AMPA receptor properties in
cerebellar stellate cells, J. Neurosci. 22 (2002) 3881–3889.
[35] K. Plant, K.A. Pelkey, Z.A. Bortolotto, D. Morita, A. Terashima, C.J. McBain, G.L.
Collingridge, J.T. Isaac, Transient incorporation of native GluR2-lacking AMPA recep-
tors during hippocampal long-term potentiation, Nat. Neurosci. 9 (2006) 602–604.
[36] H.J. Chung, J.P. Steinberg, R.L. Huganir, D.J. Linden, Requirement of AMPA receptor
GluR2 phosphorylation for cerebellar long-term depression, Science 300 (2003)
1751–1755.
[37] H. Toyoda, L.J. Wu, M.G. Zhao, H. Xu, Z. Jia, M. Zhuo, Long-term depression requires
postsynaptic AMPA GluR2 receptor in adult mouse cingulate cortex, J. Cell. Physiol.
211 (2007) 336–343.
[38] X. Bai, M.T. Wong-Riley, Neuronal activity regulates protein and gene expressions of
GluR2 in postnatal rat visual cortical neurons in culture, J. Neurocytol. 32 (2003) 71–78.
[39] M.T.Wong-Riley, P. Jacobs, AMPA glutamate receptor subunit 2 in normal andvisually
deprived macaque visual cortex, Vis. Neurosci. 19 (2002) 563–573.
[40] A.G. Rosmarin, K.K. Resendes, Z. Yang, J.N. McMillan, S.L. Fleming, GA-binding pro-
tein transcription factor: a review of GABP as an integrator of intracellular signaling
and protein–protein interactions, Blood Cells Mol. Dis. 32 (2004) 143–154.
[41] A.H. Batchelor, D.E. Piper, F.C. de la Brousse, S.L. McKnight, C. Wolberger, The struc-
ture of GABPalpha/beta: an ETS domain-ankyrin repeat heterodimer bound to DNA,
Science 279 (1998) 1037–1041.[42] K. LaMarco, C.C. Thompson, B.P. Byers, E.M. Walton, S.L. McKnight, Identiﬁcation
of Ets- and notch-related subunits in GA binding protein, Science 253 (1991)
789–792.
[43] F.C. de la Brousse, E.H. Birkenmeier, D.S. King, L.B. Rowe, S.L. McKnight, Molecular
and genetic characterization of GABP beta, Genes Dev. 8 (1994) 1853–1865.
[44] S.J. Yang, H.L. Liang, G. Ning, M.T. Wong-Riley, Ultrastructural study of
depolarization-induced translocation of NRF-2 transcription factor in cultured rat
visual cortical neurons, Eur. J. Neurosci. 19 (2004) 1153–1162.
[45] M.T. Wong-Riley, S.J. Yang, H.L. Liang, G. Ning, P. Jacobs, Quantitative immuno-
electron microscopic analysis of nuclear respiratory factor 2 alpha and beta sub-
units: normal distribution and activity-dependent regulation in mammalian visual
cortex, Vis. Neurosci. 22 (2005) 1–18.
[46] C. Zhang, M.T. Wong-Riley, Depolarizing stimulation upregulates GA-binding
protein in neurons: a transcription factor involved in the bigenomic expression of
cytochrome oxidase subunits, Eur. J. Neurosci. 12 (2000) 1013–1023.
[47] J.A. Gorter, J.J. Petrozzino, E.M. Aronica, D.M. Rosenbaum, T. Opitz, M.V. Bennett, J.A.
Connor, R.S. Zukin, Global ischemia induces downregulation of Glur2 mRNA and in-
creases AMPA receptor-mediated Ca2+ inﬂux in hippocampal CA1 neurons of gerbil,
J. Neurosci. 17 (1997) 6179–6188.
[48] S.J. Liu, R.S. Zukin, Ca2+-permeable AMPA receptors in synaptic plasticity and neu-
ronal death, Trends Neurosci. 30 (2007) 126–134.
[49] S.D. Buckingham, S. Kwak, A.K. Jones, S.E. Blackshaw, D.B. Sattelle, Edited GluR2, a
gatekeeper for motor neurone survival? Bioessays 30 (2008) 1185–1192.
[50] S. Kwak, J.H. Weiss, Calcium-permeable AMPA channels in neurodegenerative dis-
ease and ischemia, Curr. Opin. Neurobiol. 16 (2006) 281–287.
[51] H. Gollner, P. Bouwman, M. Mangold, A. Karis, H. Braun, I. Rohner, A. Del Rey, H.O.
Besedovsky, A. Meinhardt, M. van den Broek, T. Cutforth, F. Grosveld, S. Philipsen,
G. Suske, Complex phenotype of mice homozygous for a null mutation in the Sp4
transcription factor gene, Genes Cells 6 (2001) 689–697.
[52] D.M. Supp, D.P. Witte, W.W. Branford, E.P. Smith, S.S. Potter, Sp4, a member of the
Sp1-family of zinc ﬁnger transcription factors, is required for normal murine
growth, viability, and male fertility, Dev. Biol. 176 (1996) 284–299.
[53] F. Nie, M. Wong-Riley, Nuclear respiratory factor-2 subunit protein: correlation with
cytochrome oxydase and regulation by functional activity in the monkey primary
visual cortex, J. Comp. Neurol. 404 (1999) 310–320.
[54] A. Guo, F. Nie, M. Wong-Riley, Human nuclear respiratory factor 2 alpha subunit
cDNA: isolation, subcloning, sequencing, and in situ hybridization of transcripts in
normal and monocularly deprived macaque visual system, J. Comp. Neurol. 417
(2000) 221–232.
[55] Z. Wu, P. Puigserver, U. Andersson, C. Zhang, G. Adelmant, V. Mootha, A. Troy, S.
Cinti, B. Lowell, R.C. Scarpulla, B.M. Spiegelman, Mechanisms controlling mitochon-
drial biogenesis and respiration through the thermogenic coactivator PGC-1, Cell 98
(1999) 115–124.
[56] H. Meng, H.L. Liang, M. Wong-Riley, Quantitative immuno-electron microscopic
analysis of depolarization-induced expression of PGC-1alpha in cultured rat visual
cortical neurons, Brain Res. 1175 (2007) 10–16.
[57] H.L. Liang, S.S. Dhar, M.T.Wong-Riley, p38mitogen-activated protein kinase and cal-
cium channels mediate signaling in depolarization-induced activation of peroxi-
some proliferator-activated receptor gamma coactivator-1alpha in neurons, J.
Neurosci. Res. 88 (2010) 640–649.
[58] K. Vercauteren, N. Gleyzer, R.C. Scarpulla, PGC-1-related coactivator complexes with
HCF-1 and NRF-2beta in mediating NRF-2(GABP)-dependent respiratory gene ex-
pression, J. Biol. Chem. 283 (2008) 12102–12111.
[59] M. Gunther, M. Laithier, O. Brison, A set of proteins interacting with transcription
factor Sp1 identiﬁed in a two-hybrid screening, Mol. Cell. Biochem. 210 (2000)
131–142.
[60] S.S. Dhar, M.T. Wong-Riley, Chromosome conformation capture of transcriptional
interactions between cytochrome c oxidase genes and genes of glutamatergic syn-
aptic transmission in neurons, J. Neurochem. 115 (2010) 676–683.
[61] K. Johar, A. Priya, M.T. Wong-Riley, Regulation of Na(+)/K(+)-ATPase by neuron-
speciﬁc transcription factor Sp4: implication in the tight coupling of energy produc-
tion, neuronal activity and energy consumption in neurons, Eur. J. Neurosci. 39
(2013) 566–578.
